Vascular Risk Factors and Alzheimer’s Disease Pathogenesis: Are Conventional Pharmacological Approaches Protective For Cognitive Decline Progression?

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|14|2|257-269

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.14, Iss.2, 2015-03, pp. : 257-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dietary Approaches and Supplements in the Prevention of Cognitive Decline and Alzheimer’s Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 6, 2016-02 ,pp. : 688-700

Bentham Science Publishers

Access to resources Recommend Favorite

Galantamine in the Treatment of Cognitive Decline in Patients with Vascular Dementia or Alzheimer’s Disease with Cerebrovascular Disease

By Small G.  

CNS Drugs, Vol. 17, Iss. 12, 2003-01 ,pp. : 905-914

Adis International

Access to resources Recommend Favorite

Abnormal APP processing in platelets of patients with Alzheimer’s disease: correlations with membrane fluidity and cognitive decline

By Zainaghi Isis   Forlenza Orestes   Gattaz Wagner  

Psychopharmacology, Vol. 192, Iss. 4, 2007-07 ,pp. : 547-553

Springer Publishing Company

Access to resources Recommend Favorite

Aging process, cognitive decline and Alzheimer`s disease: can strength training modulate these responses?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 9, 2015-11 ,pp. : 1209-1213

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological strategies for the prevention of Alzheimer’s disease

By Doraiswamy P Murali   Xiong Glen L  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 1, 2006-01 ,pp. : 1-10

Informa Healthcare

Access to resources Recommend Favorite